The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Artificial Lung Global Market Report 2023, the artificial lung market is expected to show significant growth in the forecast period.

• Market Expansion: The artificial lung market has experienced significant growth, increasing from $2.06 billion in 2023 to $2.31 billion in 2024, with a CAGR of 11.9%.
• Key Drivers:
  • Healthcare Professional Awareness: Increased understanding and utilization of artificial lung technologies among healthcare professionals.
  • Market Penetration: Growing acceptance and use of artificial lungs in various medical settings.
  • Home Care Applications: Expanded applications in home care settings, offering patients more accessible treatment options.
  • Medical Tourism: Rising medical tourism has increased access to advanced medical technologies, driving market growth.
  • Healthcare Infrastructure: Continuous improvements in healthcare infrastructure have facilitated the adoption of advanced respiratory support systems.

View More On The Artificial Lung Market Report 2024 –https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Promising Future Growth and Trends

• Future Market Growth: The artificial lung market is projected to grow to $3.63 billion by 2028, with a CAGR of 12.0%.
• Growth Factors:
  • Prevalence of Respiratory Diseases: The increasing number of respiratory disease cases globally is a major driver for the market.
  • Healthcare Facilities: Continuous improvements in healthcare facilities enhance the market’s growth prospects.
  • Minimally Invasive Procedures: The rising acceptance of minimally invasive procedures is boosting demand for artificial lungs.
  • Patient Quality of Life: These technologies improve patients’ quality of life by providing effective respiratory support.
  • Chronic Diseases: The rising prevalence of chronic obstructive pulmonary diseases (COPD) further fuels market expansion.
• Emerging Trends:
  • Wireless Technology: Integration of wireless technology for easier monitoring and control of artificial lung systems.
  • Artificial Intelligence: AI integration enhances diagnostics, treatment personalization, and overall system efficiency.
  • Genomics and Medical Technology: Advances in these areas are driving the development of more effective artificial lung devices.
  • Portable Devices: The development of smaller, portable artificial lungs allows for greater patient mobility and comfort.

Rising Respiratory Diseases Drive Market Growth

• Disease Prevalence: The increasing prevalence of respiratory diseases is a key factor driving the artificial lung market.
• Contributing Factors:
  • Air Pollution and Climate Change: These environmental factors contribute to the rise in respiratory conditions.
  • Lifestyle Changes: Shifts in lifestyle have also led to an increase in respiratory diseases.
• Artificial Lung Applications:
  • Respiratory Support: Artificial lungs provide critical oxygenation and carbon dioxide removal, supporting or replacing impaired lung function.
  • Healthcare Impact: These devices are vital in treating conditions like asthma and COPD, improving patient outcomes.
• Example: In June 2024, the Australian Institute of Health and Welfare reported that approximately 8.5 million Australians (34% of the population) have chronic respiratory conditions, emphasizing the growing need for advanced respiratory support systems.

Innovations in Respiratory Support Systems

• Technological Advancements: Companies in the artificial lung market are focusing on developing innovative respiratory support systems.
• Case Study – ALung Technologies:
  • FDA Approval: In December 2021, ALung Technologies Inc. received FDA approval for its Hemolung Respiratory Support System, a groundbreaking artificial lung device.
  • Device Features:
    • ECCO2R System: Provides extracorporeal carbon dioxide removal (ECCO2R) from the blood for up to 5 days.
    • Application: Designed for adults with acute, reversible respiratory failure when traditional ventilation is inadequate.
    • Significance: This approval marks a significant advancement in respiratory support technology, offering a new treatment option for patients with severe respiratory conditions.

Strategic Acquisitions Enhance Market Position

• LivaNova plc’s Acquisition of ALung Technologies:
  • Expansion of Portfolio: In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to expand its respiratory therapy portfolio.
  • Strategic Goals:
    • Innovative Solutions: The acquisition enhances LivaNova’s capacity to offer advanced respiratory support solutions.
    • Focus on Artificial Lungs: The acquisition emphasizes the development and expansion of artificial lung technologies.
  • ALung Technologies: A US-based company specializing in gas exchange devices for treating acute and chronic respiratory disorders, further strengthening LivaNova’s market position.

Market Segmentation and Regional Insights

• Product Types:
  • Single Roller Pump Heart Lung Machines
  • Double Roller Pump Heart Lung Machines
  • Bubble Artificial Lungs
  • Membrane Artificial Lungs
• Applications:
  • Cardiac Surgery
  • Lung Transplant Operations
  • Acute Respiratory Failure Treatment
  • Other Applications
• End-Users:
  • Hospitals
  • Emergency Centers
  • Other End-users
• Regional Analysis: North America was the largest region in the artificial lung market in 2023, driven by advanced healthcare infrastructure and high adoption rates of innovative medical technologies.

Conclusion

The artificial lung market is on a rapid growth trajectory, driven by increasing respiratory disease prevalence, technological advancements, and strategic industry developments. With continued innovation and expanding applications, artificial lung technologies are set to play a crucial role in the future of respiratory care.

Request A Sample Of The Global Artificial Lung Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16591&type=smp